Mereo BioPharma Group plc - Ordinary Shares (MREO)

CUSIP: 589492107

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+33,088,323
Put/Call ratio
120%
SEC-reported price per share
$3.37
Indexed holders
64
Value change
+$110,829,354
Number of buys
46
Open additional details 1 more signal available
Number of sells
17
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
833,333,333

Security key

589492107

Report period

Q1 2021

Indexed institutions

64

Top holders

10

Ownership snapshot

Top reported holders of MREO - Mereo BioPharma Group plc - Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Boxer Capital, LLC
Disclosed value leader
Boxer Capital, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F Highest disclosed value: $22,291,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Boxer Capital, LLC has the largest disclosed position value at $22.29M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Boxer Capital, LLC's linked filing trail.
Disclosed position value Top 5
Boxer Capital, LLC $22.29M
BAKER BROS. ADVISORS LP $21.59M
Vivo Capital, LLC $15.11M
CITADEL ADVISORS LLC $14.73M
HHLR ADVISORS, LTD. $10.66M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Boxer Capital, LLC
13F
Company
13F
—
denominator unverified
$22,291,000
6,226,673 shares
— 31 Dec 2020
BAKER BROS. ADVISORS LP
13F
Company
13F
—
denominator unverified
$21,588,000
6,030,293 shares
— 31 Dec 2020
Vivo Capital, LLC
13F
Company
13F
—
denominator unverified
$15,111,000
4,220,938 shares
— 31 Dec 2020
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$14,733,000
4,115,455 shares
— 31 Dec 2020
HHLR ADVISORS, LTD.
13F
Company
13F
—
denominator unverified
$10,655,000
2,976,121 shares
— 31 Dec 2020
MONTANOVA CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$9,841,000
2,748,999 shares
— 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
64
Shares
90,226,943
Indexed holders
64
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 indexed holders
44
Q1 2021 indexed holders
64
Indexed holder difference
20
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .